TFQI-fT3

Biomarker

1 paper2 findings

  • Humans1

Associations

2

Abnormal ST segments

downin humans1OR 0.57

1 study
  1. TFQI-fT3 lowers the risk of abnormal ST segments in humans (OR 0.57, 95% CI 0.32-0.97).

    Humansyounger adults

    Age-related changes in HPT axis sensitivity and their associations with metabolic and cardiovascular health: a cross-sectional, Chinese nationwide study

    Frontiers in endocrinology9 Sep 2026

Metabolic syndrome

downin humans1OR 0.79

1 study
  1. TFQI-fT3 lowers the risk of metabolic syndrome in humans (OR 0.79, 95% CI 0.65-0.97).

    Humansolder adults (>48 years)

    Age-related changes in HPT axis sensitivity and their associations with metabolic and cardiovascular health: a cross-sectional, Chinese nationwide study

    Frontiers in endocrinology9 Sep 2026

More on Metabolic syndrome

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01 in 12 months